# Multi-analyte Blood Test Clinical Trial

> **NCT05199259** · — · RECRUITING · sponsor: **Helio Genomics** · enrollment: 1200 (estimated)

## Conditions studied

- Liver Cirrhosis
- Liver Cancer
- HCC
- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Multi-analyte Blood Test

## Key facts

- **NCT ID:** NCT05199259
- **Lead sponsor:** Helio Genomics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199259, "Multi-analyte Blood Test Clinical Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05199259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*